Dudediligence.

Heron Therapeutics, Inc

HRTXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$32.8MSep ’24$40.8MDec ’24$38.9MMar ’25$37.2MJun ’25$38.2MSep ’25$40.6MDec ’25$34.7MMar ’26$37.7MJun ’26
Net income, by quarter
−$4.8MSep ’24$3.7MDec ’24$2.6MMar ’25−$2.4MJun ’25−$17.5MSep ’25−$2.8MDec ’25−$8.1MMar ’26−$5.5MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$86.3M$107.7M$127.0M$144.3M$154.9M
Gross profit$40.3M$52.8M$61.9M$105.6M$113.6M
Operating income−$217.8M−$174.7M−$110.6M−$11.5M−$2.5M
Net income−$220.7M−$182.0M−$110.6M−$13.6M−$20.0M
Operating cash flow−$203.4M−$146.9M−$58.8M−$22.5M−$27.6M
Free cash flow−$206.4M−$148.7M−$60.3M−$24.2M−$27.9M
Cash$90.5M$15.4M$28.7M$25.8M$28.6M
Shares outstanding102.0M119.2M150.3M152.1M188.3M